Arrowstreet Capital Limited Partnership Grows Stock Position in Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH)

Arrowstreet Capital Limited Partnership boosted its stake in shares of Aveanna Healthcare Holdings Inc. (NASDAQ:AVAH) by 15.4% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 282,876 shares of the company’s stock after purchasing an additional 37,801 shares during the period. Arrowstreet Capital Limited Partnership’s holdings in Aveanna Healthcare were worth $1,293,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in AVAH. KLP Kapitalforvaltning AS acquired a new stake in Aveanna Healthcare during the 4th quarter worth approximately $35,000. Catalyst Funds Management Pty Ltd lifted its stake in shares of Aveanna Healthcare by 321.4% during the fourth quarter. Catalyst Funds Management Pty Ltd now owns 11,800 shares of the company’s stock worth $54,000 after purchasing an additional 9,000 shares in the last quarter. Arizona State Retirement System purchased a new stake in shares of Aveanna Healthcare in the fourth quarter worth about $64,000. EntryPoint Capital LLC purchased a new position in Aveanna Healthcare in the 4th quarter worth approximately $68,000. Finally, XTX Topco Ltd purchased a new position in shares of Aveanna Healthcare in the third quarter valued at $92,000. Institutional investors and hedge funds own 87.96% of the company’s stock.

Insider Activity at Aveanna Healthcare

In related news, major shareholder J.H. Whitney Equity Partners V sold 5,580 shares of Aveanna Healthcare stock in a transaction dated Tuesday, April 1st. The shares were sold at an average price of $5.63, for a total value of $31,415.40. Following the sale, the insider now directly owns 1,451,598 shares in the company, valued at $8,172,496.74. This trade represents a 0.38 % decrease in their position. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Insiders sold 67,412 shares of company stock worth $372,142 in the last 90 days. 7.80% of the stock is currently owned by company insiders.

Analyst Ratings Changes

Several research analysts recently commented on the company. UBS Group boosted their price target on Aveanna Healthcare from $3.20 to $4.50 and gave the stock a “sell” rating in a research note on Friday, March 14th. Truist Financial reduced their target price on Aveanna Healthcare from $6.00 to $5.50 and set a “hold” rating on the stock in a report on Friday.

Aveanna Healthcare Stock Down 6.5 %

Shares of NASDAQ AVAH opened at $4.49 on Friday. The firm’s 50-day moving average price is $4.79 and its two-hundred day moving average price is $4.93. The stock has a market capitalization of $875.97 million, a P/E ratio of -13.21 and a beta of 1.99. Aveanna Healthcare Holdings Inc. has a 52-week low of $2.11 and a 52-week high of $6.19.

About Aveanna Healthcare

Aveanna Healthcare Holdings Inc, a diversified home care platform company, provides pediatric and adult healthcare services in the United States. Its patient-centered care delivery platform allows patients to remain in their homes and minimizes the overutilization of high-cost care settings, such as hospitals or skilled nursing facilities.